Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Gene Therapy for Alzheimer's Disease Clinical Trial (NCT00017940)The Shiley Family Trust
SARS Coronavirus Vaccine (SARS-CoV) (NCT00533741)National Institute of Allergy and Infectious Diseases (NIAID)
An Open-Label Evaluation of the Independent Effects of Coadministration of a High-Fat Meal and Naltrexone Blockade on the Pharmacokinetic Profile of Dilaudid OROS (Hydromorphone HCI) 16mg (NCT00399295)Alza Corporation, DE, USA
Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema (NCT00318513)Premiere Oncology of Arizona
Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents (NCT00011479)National Institute of Allergy and Infectious Diseases (NIAID)
Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00072228)Daiichi Pharmaceuticals
A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children (NCT00001106)National Institute of Allergy and Infectious Diseases (NIAID)
Bioavailability of Prochlorperazine Suppositories, 25 mg (NCT00992472)Padagis LLC
Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults (NCT00000877)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC) (NCT00001006)National Institute of Allergy and Infectious Diseases (NIAID)
Amphetamine Cocaine Interaction Study - 2 (NCT00000305)The University of Texas Health Science Center, Houston
The Effects of Pre-operative Magic Tricks Performance on Pre-operative Anxiety in Children (NCT00535457)Sheba Medical Center
Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies (NCT00081549)Aronex Pharmaceuticals
Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome (NCT00000726)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59 (NCT00000632)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons (NCT00001060)National Institute of Allergy and Infectious Diseases (NIAID)
A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV Treatment (NCT00002243)Sarawak MediChem Pharmaceuticals
Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children (NCT00006325)National Institute of Allergy and Infectious Diseases (NIAID)
Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection (NCT00125099)National Institute of Allergy and Infectious Diseases (NIAID)
Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems (NCT00006066)National Institute of Allergy and Infectious Diseases (NIAID)
The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections (NCT00001035)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of CI-1012 in HIV-Infected Patients (NCT00002196)Parke-Davis
Vertical Stability Training Effects on the Eye-Hand Coordination of Female Volleyball Players (NCT01197430)Taipei Physical Education College
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Alfuzosin ER Tablets Under Fed Conditions (NCT01418599)Torrent Pharmaceuticals Limited
A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients (NCT00000899)National Institute of Allergy and Infectious Diseases (NIAID)
Bioequivalence Study of Risperidone 1 mg Tablets of Torrent Pharmaceuticals Limited, India and Risperdal® (Risperidone) 1 mg Tablets of Janssen Pharmaceutical Products, LP, USA, in Healthy Human Adult Subjects, Under Fed Conditions (NCT00939926)Torrent Pharmaceuticals Limited
A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease (NCT00000656)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes (NCT00000645)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Randomized Dose/Formulation Comparison Study of SC-52151 (NCT00000806)National Institute of Allergy and Infectious Diseases (NIAID)
Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease (NCT01084486)Wolfson Medical Center
The Effects of OC000459 on Nasal Mediators (NCT00290381)Trevor Hansel
The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients (NCT00002311)Mucos Pharma GmbH and Co
Evaluation of Omeprazole Effect on Glaucoma (NCT01000220)Shahid Beheshti University of Medical Sciences
Synchronization and Desynchronization Between Circadian Rhythms in Patients With Delayed Sleep Phase Syndrome (DSPS) (NCT00282061)Sheba Medical Center
Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452 (NCT00006495)National Institute of Allergy and Infectious Diseases (NIAID)
Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection (NCT00000739)National Institute of Allergy and Infectious Diseases (NIAID)
Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution (NCT00260767)Biosyn
A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients (NCT00002198)Glaxo Wellcome
A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI) (NCT00000742)National Institute of Allergy and Infectious Diseases (NIAID)
Local Application of Autologous Bone Marrow Cells for Treatment of Chronic Diabetic Ulcers (NCT00292357)Heidelberg University
Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors (NCT00102830)Amgen
The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs (NCT00017758)National Institute of Allergy and Infectious Diseases (NIAID)
Comparing the Effect of Vaginal Misoprostol With Dinoprostone in Term Pregnancies (NCT00432588)Hormozgan University of Medical Sciences
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants (NCT00433485)Yale University
A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients (NCT00000768)National Institute of Allergy and Infectious Diseases (NIAID)
An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer (NCT00051779)Chugai Pharma USA
Steady State Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets (NCT01634373)Torrent Pharmaceuticals Limited
A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC) (NCT00000978)National Institute of Allergy and Infectious Diseases (NIAID)
A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin (NCT00000778)National Institute of Allergy and Infectious Diseases (NIAID)
Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC (NCT00026624)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines (NCT00000746)National Institute of Allergy and Infectious Diseases (NIAID)
Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex (NCT00000692)G D Searle
Efficacy and Safety of the Hcoil Deep TMS for the Treatment of Cannabis Addiction (NCT00543036)Shalvata Mental Health Center
A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children (NCT00000827)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy Adults (NCT00000853)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines (NCT00002402)VaxGen
A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection (NCT00002183)Glaxo Wellcome
Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir® (NCT00622141)The HIV Netherlands Australia Thailand Research Collaboration
Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets (NCT00000102)National Center for Research Resources (NCRR)
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02050009)Fox Chase Cancer Center
A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure (NCT00487799)Facet Biotech
Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis (NCT00043706)Genzyme, a Sanofi Company
A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects (NCT00000845)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma (NCT00000681)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers (NCT00001992)Genentech, Inc.
A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia (NCT00002258)Sandoz
Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants (NCT00038480)National Institute of Allergy and Infectious Diseases (NIAID)
Safety/ Feasibility of Percutaneous Administration of Vonapanitase as Monotherapy for Peripheral Artery Disease (PAD) of the SFA and Popliteal Arteries (NCT02953496)Proteon Therapeutics
A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin (NCT00358553)Baxter Healthcare Corporation
A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine (NCT00001136)National Institute of Allergy and Infectious Diseases (NIAID)
Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer (NCT00416325)University of Illinois at Chicago
Impact of Consumption of Oats in Lipid Profile of Children and Adolescents With Dyslipidemia (NCT01581697)Instituto de Cardiologia do Rio Grande do Sul
Alterations in Serotonergic Functions in Cocaine Addicts - 1 (NCT00000312)National Institute on Drug Abuse (NIDA)
Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides (NCT01645293)University of Cologne
Single Dose Pharmacodynamic and Pharmacokinetic Study of DG3173 (NCT02217826)Aspireo Pharmaceuticals Limited
Effects of SQ109 on QTc Interval in Healthy Subjects (NCT01874314)National Institute of Allergy and Infectious Diseases (NIAID)
Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy (NCT00107549)National Institute of Allergy and Infectious Diseases (NIAID)
Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT00995059)Mayo Clinic
Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children (NCT00000773)National Institute of Allergy and Infectious Diseases (NIAID)
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients (NCT00002128)Gilead Sciences
A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS (NCT00000992)National Institute of Allergy and Infectious Diseases (NIAID)
Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer (NCT00093548)Jonsson Comprehensive Cancer Center
A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa (NCT00304668)International Partnership for Microbicides, Inc.
Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus Vaccine (NCT02684383)National Institute of Allergy and Infectious Diseases (NIAID)
A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women (NCT00000864)National Institute of Allergy and Infectious Diseases (NIAID)
The Effect of Gabapentin (Neurentin) and Pregabalin (Lyrica) in Pain Reduction After Photorefractive Keratectomy (NCT01122004)Shahid Beheshti University of Medical Sciences
Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity (NCT00000977)National Institute of Allergy and Infectious Diseases (NIAID)
Early Tobacco Abstinence - 5 (NCT00224965)National Institute on Drug Abuse (NIDA)
Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery (NCT00041691)Gilead Sciences
A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers (NCT00001090)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection (NCT00000984)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers (NCT00001055)National Institute of Allergy and Infectious Diseases (NIAID)
Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD) (NCT00211419)Manhattan Eye, Ear & Throat Hospital
A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone (NCT00000788)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160 (NCT00000956)National Institute of Allergy and Infectious Diseases (NIAID)
Outcome of Crisis Intervention for Subjects With Borderline Personality Disorder or Post-Traumatic Stress Disorder (NCT00269139)Laddis, Andreas, M.D.
The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected Patients (NCT00002346)Gilead Sciences
A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma (NCT00000954)National Institute of Allergy and Infectious Diseases (NIAID)
Safety Study of Prucalopride in Healthy Volunteers (NCT00793429)Movetis
Chinese Exercise Modalities in Parkinson's Disease (NCT00029809)National Center for Complementary and Integrative Health (NCCIH)
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.